Metastatic Castration-resistant Prostate CancerФаза 2NCT06922318
The COSMYC Trial (COmbined Suppression of MYC)
ZEN-3694, Testosterone cypionate, Enzalutamide, Luteinizing hormone-releasing hormone (LHRH) analogue
52 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Prostate52 studies
Metastatic Castration-resistant Prostate CancerФаза 2NCT06922318
ZEN-3694, Testosterone cypionate, Enzalutamide, Luteinizing hormone-releasing hormone (LHRH) analogue
Prostate CancerФаза 2NCT05790213Papers
Androgen Deprivation Therapy (ADT), Focal prostate ablation (focal therapy)
Prostate CancerФаза 2NCT06392295
Para Aortic Radiation Therapy: Photon Therapy, Para Aortic Radiation Therapy: Proton Therapy, Androgen Deprivation Therapy, Androgen Receptor Signaling Inhibitor
Metastatic CancerФаза 2NCT05422911
Abiraterone acetate, Apalutamide, Enzalutamide